🔍
Search Results - psychiatric+diseases
14
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A DNA methylation and genotype specific biomarker of suicide attempt
Novel Biomarkers for Predicting Suicide RiskJHU REF: [C12394]Invention Novelty: This invention provides DNA methylation-based biomarkers for predicting suicide risk. Value Proposition: Almost 30,000 people die of suicide each year in the United States, and 1 million people die worldwide. In the teenage population, it is the second leading cause of...
Published: 3/13/2025
|
Inventor(s):
Holly Wilcox
,
Zachary Kaminsky
Keywords(s):
Biomarker
,
Clinical Diagnostics
,
CNS and Neurological Disorders
,
Disease Indication
,
Epigenetic
,
In Vitro Diagnostics
,
In Vitro Diagnostics (Old)
,
Methylation
,
Prognostic Biomarker
,
Psychiatric Diseases
,
Suicidal Impulses
,
Suicide/Suicidal Impulses
Category(s):
Clinical and Disease Specializations
,
Technology Classifications > Diagnostics > Biomarkers
,
Technology Classifications > Diagnostics > In Vitro Diagnostics
,
Technology Classifications > Diagnostics > Prognostics Biomarkers
,
Technology Classifications > Diagnostics
,
Clinical and Disease Specializations > Psychiatry
,
Clinical and Disease Specializations > Psychiatry > Suicidal Impulses
DNA Methylation Biomarkers of Post Partum Depression Risk
Invention Novelty: This invention provides DNA methylation-based biomarkers for predicting postpartum depression (PPD) risk . Value Proposition: PPD occurs in approximately 10-15% of women and represents a serious health risk to both mothers and their offspring. Increased depression risk in pregnant women is not predicted by hormonal fluctuations. This...
Published: 3/13/2025
|
Inventor(s):
Zachary Kaminsky
,
Jennifer Payne
,
Todd Gould
Keywords(s):
Biomarker
,
Clinical Diagnostics
,
CNS and Neurological Disorders
,
Disease Indication
,
In Vitro Diagnostics
,
Post Partum Depression
,
Postpartum Depression
,
Prognostic Biomarker
,
Psychiatric Diseases
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Women's Health
,
Technology Classifications > Diagnostics > Biomarkers
,
Technology Classifications > Diagnostics > In Vitro Diagnostics
,
Technology Classifications > Diagnostics > Prognostics Biomarkers
,
Technology Classifications > Diagnostics
,
Clinical and Disease Specializations > Psychiatry
,
Clinical and Disease Specializations > Psychiatry > Postpartum Depression
Novel Therapeutic Target for Neural Regeneration, Stroke and Anti-depressants
Unmet needCurrent anti-depressants in the market have various limitations including lack of broad-spectrum drugs, unexpected side effects, toxicity and low efficacy for certain patients. New generation of anti-depressants based on most recent biomedical discoveries concerning depression are urgently needed. Technology overviewJohns Hopkins researchers...
Published: 3/13/2025
|
Inventor(s):
Dengke Ma
,
Guo-li Ming
,
Hongjun Song
Keywords(s):
Biomarker
,
CNS and Neurological Disorders
,
Disease Indication
,
Mechanism of Action Biomarker
,
Psychiatric Diseases
,
Stroke
,
Therapeutic Matter
,
Therapeutics
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Neurology
,
Clinical and Disease Specializations > Neurology > Stroke
,
Clinical and Disease Specializations > Psychiatry
,
Technology Classifications > Diagnostics
,
Technology Classifications > Diagnostics > Biomarkers
,
Technology Classifications > Therapeutic Modalities
,
Technology Classifications > Therapeutic Modalities > Targets
C14346 - New, Simple and Quick Test to Diagnose, Predict, and Prevent Brain Disorders Using Non-invasive Nasal Brush and Single-Cell Analysis
Invention novelty: This technology is the first clinical assay to measure biological markers that reflect symptom severity and drug efficacy for mental disorders, such as depression and schizophrenia. This tool is useful for not only diagnosing such disorders, but also predicting them before onset, choosing the best treatments for individual patients,...
Published: 3/13/2025
|
Inventor(s):
Akira Sawa
,
Koko Ishizuka
,
Yeewen Wu
,
Youjin Chung
,
Nao Gamo
Keywords(s):
Biopsy Tools
,
Clinical Diagnostics
,
CNS and Neurological Disorders
,
Diagnostic Tool
,
Disease Indication
,
Psychiatric Diseases
,
Schizophrenia
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Psychiatry > Schizophrenia
,
Technology Classifications > Diagnostics > In Vitro Diagnostics
,
Technology Classifications > Diagnostics
,
Clinical and Disease Specializations > Psychiatry
Method to Determine Risk of Developing PTSD after Stressful Events
Unmet Need:Post-traumatic stress disorder (PTSD) is recognized by the Department of Defense, the Department of Veterans Affairs, and the National Institute of Mental Health as a major medical issue for both deployed and returning U.S. troops. PTSD rates in military personnel following deployment range from 5 to 15% (Sundin et al, 2010; Reijnen et al,...
Published: 3/13/2025
|
Inventor(s):
Zachary Kaminsky
,
Marco Boks
Keywords(s):
Biomarker
,
Clinical Diagnostics
,
CNS and Neurological Disorders
,
Disease Indication
,
In Vitro Diagnostics
,
Post-Traumatic Stress Disorder
,
Post-Traumatic Stress Disorder (PTSD)
,
Prognostic Biomarker
,
Psychiatric Diseases
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Psychiatry > Post-Traumatic Stress Disorder
,
Technology Classifications > Diagnostics > Biomarkers
,
Technology Classifications > Diagnostics > In Vitro Diagnostics
,
Technology Classifications > Diagnostics > Prognostics Biomarkers
,
Technology Classifications > Diagnostics
,
Clinical and Disease Specializations > Psychiatry
Multiple Lines of Induced Pluripotent Stem Cells (iPSCs) Derived from Members of an American Family with, and without DISC1 Mutations Associated with Schizophrenia and Depression
Invention Novelty: These tangible materials are induced Pluripotent Stem Cells (iPSCs) derived from members with or without DISC1 (Disrupted in schizophrenia 1) mutations in an American family associated with schizophrenia. Value Proposition:Mutations in DISC1 have been shown to predispose individuals to the development of psychiatric illnesses such...
Published: 3/13/2025
|
Inventor(s):
Hongjun Song
,
Christopher Ross
,
Guo-li Ming
,
Russell Margolis
Keywords(s):
Cell Model
,
CNS and Neurological Disorders
,
Discovery/Research Tools
,
Disease Indication
,
In Vitro Research Tool
,
Psychiatric Diseases
,
Schizophrenia
,
Stem Cells
,
Target-based Screening Tool
,
Translational Research Biomarker
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Psychiatry > Schizophrenia
,
Technology Classifications > Diagnostics > In Vitro Diagnostics
,
Technology Classifications > Research Tools
,
Technology Classifications > Research Tools > Cell Lines
,
Technology Classifications > Research Tools > Stem Cells
,
Technology Classifications > Diagnostics
,
Clinical and Disease Specializations > Psychiatry
,
Technology Classifications > Research Tools > Human Cell Lines
Homozygous Mutant DISC1 Mice, Lines 1001 and 1302
Homozygous Mutant DISCI MiceJHU REF: C11617 Invention Novelty: The disclosed technologies are two tangible materials that are improved homozygous mouse strains with inducible expression of mutant human Disrupted-In-Schizophrenia-1 (hDISC1) using Tet-off system under the control of CAMKII. Value Proposition: The disclosed materials are improved...
Published: 3/13/2025
|
Inventor(s):
Mikhail Pletnikov
Keywords(s):
Basic Research Biomarker
,
Cell Lines
,
CNS and Neurological Disorders
,
Discovery/Research Tools
,
Disease Indication
,
In Vitro Research Tool
,
In Vivo Research Tool
,
Mouse Cell Lines
,
Mouse Model
,
Psychiatric Diseases
,
Schizophrenia
,
Target
,
Therapeutic Matter
,
Therapeutics
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Psychiatry > Schizophrenia
,
Technology Classifications > Research Tools > Animal Models
,
Technology Classifications > Research Tools > Cell Lines
,
Clinical and Disease Specializations > Psychiatry
,
Technology Classifications > Research Tools
,
Technology Classifications > Therapeutic Modalities > Targets
024414 B6129(SJL)-Grip1-tm1Rlh, 024415 B6.129S6(Cg)-Wwc1-tm1.1Rlh, 024417 B6.129S6(SJL)-Prkcz-tm1.1Rlh, 024418 B6.129S6-Gria1-tm7Rlh, 024419 B6.129(Cg)-Gria2-tm2Rlh, 024420 B6.129(Cg)-Gria1-tm4Rlh
TITLE: 024414 B6.129(SJL)-Grip1tm1Rlh 024415 B6.129S6(Cg)-Wwc1tm1.1Rlh024417 B6.129S6(SJL)-Prkcz tm1.1Rlh024418 B6.129S6-Gria1tm7Rlh 024419 B6.129(Cg)-Gria2tm2Rlh024420 B6.129(Cg)-Gria1tm4Rlh CASE NUMBER: C13635ABSTRACTInformation are from Jacksons Lab website (https://www.jax.org/mouse-search?searchTerm=Richard%20Huganir)Stock No. 024414 B6.129(SJL)-Grip1tm1Rlh...
Published: 3/13/2025
|
Inventor(s):
Richard Huganir
Keywords(s):
CNS and Neurological Disorders
,
Discovery/Research Tools
,
Disease Indication
,
In Vivo Research Tool
,
Knock Out Mouse Model
,
Mouse Model
,
Psychiatric Diseases
,
Translational Research Biomarker
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Psychiatry
,
Technology Classifications > Research Tools > Animal Models
,
Technology Classifications > Research Tools
iPSCs from Schizophrenia patents with a DISC1 mutation
C11364: Schizophrenia Associated Induced Pluripotent Stem Cell LinesNovelty: Induced Pluripotent Stem Cell (iPSC) lines derived from somatic cells from members of an American family with schizophrenia and without a schizophrenia diagnosisValue Proposition: Mutations in the Disrupted-in-Schizophrenia 1 (DISC1) gene have been shown to predispose individuals...
Published: 3/13/2025
|
Inventor(s):
Guo-li Ming
,
Christopher Ross
,
Russell Margolis
,
Hongjun Song
Keywords(s):
Basic Research Biomarker
,
Cell Model
,
CNS and Neurological Disorders
,
Discovery/Research Tools
,
Disease Indication
,
In Vitro Research Tool
,
Psychiatric Diseases
,
Schizophrenia
,
Stem Cells
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Psychiatry > Schizophrenia
,
Technology Classifications > Research Tools > Cell Lines
,
Technology Classifications > Research Tools > Stem Cells
,
Clinical and Disease Specializations > Psychiatry
,
Technology Classifications > Research Tools
Novel Compounds targeting GAPDH-Siah Cell Death Cascade
Novel Compounds targeting GAPDH-Siah Cell Death Cascade JHU Ref #: C11114 Value Proposition Targeted therapy: Small molecule compound that inhibits the GAPDH-Siah cell cascade to prevent cell death in degenerative diseases Broad Application: Effective across stress-mediated conditions, including Alzheimer’s, Parkinson’s, stroke,...
Published: 3/13/2025
|
Inventor(s):
Neelam Shahani
,
Toshiaki Saito
,
David Kass
,
Eiki Takimoto
,
Akira Sawa
Keywords(s):
Alzheimer's Disease
,
Antagonists/Inhibitors
,
Biomarker
,
CNS and Neurological Disorders
,
Disease Indication
,
Huntington's Disease
,
Mechanism of Action Biomarker
,
Neurodegenerative Diseases
,
Non-novel
,
Novel
,
Predicted Novelty
,
Psychiatric Diseases
,
Repurposed
,
Schizophrenia
,
Small Molecules
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Psychiatry > Schizophrenia
,
Technology Classifications > Diagnostics > Biomarkers
,
Technology Classifications > Therapeutic Modalities > Small Molecules
,
Technology Classifications > Therapeutic Modalities > Targets
,
Technology Classifications > Diagnostics
,
Clinical and Disease Specializations > Psychiatry
,
Technology Classifications > Therapeutic Modalities
,
Clinical and Disease Specializations > Neurology > Alzheimer's Disease
,
Clinical and Disease Specializations > Neurology > Huntington's Disease
,
Clinical and Disease Specializations > Neurology > Parkinson’s Disease
1
2
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum